These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31677120)

  • 1. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.
    Nguyen ML; Sunderland B; Lim S; Hattingh L; Chalmers L
    Int J Clin Pharm; 2019 Dec; 41(6):1642-1651. PubMed ID: 31677120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the prescribing patterns of antipsychotic medication in a rural England Community Mental Health Team.
    Seshadri M; Elsemary A; Thalitaya MD; Chikodzore L; Nagalingam P
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):524-529. PubMed ID: 28953820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Concurrent Oral and Long-Acting Injectable Antipsychotic Prescribing at the Minneapolis Veterans Affairs Health Care System.
    Dimitropoulos E; Drogemuller L; Wong K
    J Clin Psychopharmacol; 2017 Oct; 37(5):605-608. PubMed ID: 28816923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
    Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
    Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
    [No Abstract]   [Full Text] [Related]  

  • 5. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
    Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
    Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.
    Ganguly R; Kotzan JA; Miller LS; Kennedy K; Martin BC
    J Clin Psychiatry; 2004 Oct; 65(10):1377-88. PubMed ID: 15491242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic Polypharmacy Among Patients With Schizophrenia in Africa: A Systematic Review and Meta-Analysis.
    Ayenew W; Asmamaw G; Bitew T
    Int J Neuropsychopharmacol; 2021 Dec; 24(12):956-964. PubMed ID: 34245271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
    Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
    CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.
    Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR
    Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic prescribing in Black and White hospitalised patients.
    Connolly A; Taylor D; Sparshatt A; Cornelius V
    J Psychopharmacol; 2011 May; 25(5):704-9. PubMed ID: 21511740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic polypharmacy in schizophrenia: benefits and risks.
    Barnes TR; Paton C
    CNS Drugs; 2011 May; 25(5):383-99. PubMed ID: 21476610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosage patterns of antipsychotic drugs for the treatment of schizophrenia in Swedish ambulatory clinical practice--a highly individualized therapy.
    Bingefors K; Isacson D; Lindström E
    Nord J Psychiatry; 2003; 57(4):263-9. PubMed ID: 12888400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.
    Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC
    Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incident users of antipsychotics: who are they and how do they fare?
    Baandrup L; Kruse M
    Soc Psychiatry Psychiatr Epidemiol; 2016 Apr; 51(4):505-12. PubMed ID: 26409887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis.
    Lee LHN; Procyshyn RM; White RF; Woodward TS; Honer WG; Barr AM
    PLoS One; 2018; 13(8):e0199758. PubMed ID: 30096136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New users of antipsychotic medication: A population-based cohort study of occupational outcome measures in relation to antipsychotic on-label and off-label prescribing practices.
    Baandrup L; Kruse M
    Eur Psychiatry; 2016 Jan; 31():66-71. PubMed ID: 26437772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of depot antipsychotic prescribing in southern Adelaide.
    Herriot P; Kheirani K
    Australas Psychiatry; 2005 Sep; 13(3):253-7. PubMed ID: 16174198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting high-dose and combined antipsychotic prescribing in New Zealand: High-dose antipsychotic prescribing.
    Burness C; Corbet C; Beyene K; Webby C; Nankivell C; Cabasag P; Hari K; Fraser A; Gray S; Harrison J; Chan AHY
    Psychiatry Res; 2021 Aug; 302():113996. PubMed ID: 34126462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of high-dose antipsychotic prescription in psychiatric patients in Hong Kong.
    Hung GB; Cheung HK
    Hong Kong Med J; 2008 Feb; 14(1):35-9. PubMed ID: 18239241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting.
    Julaeha J; Athiyah U; Hermansyah A
    J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31837257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.